Product Code: 1227
Global Corneal Implants Market is expected to foster appreciable growth opportunities and garner a decent valuation by 2030, owing to the increasing technological advancements in corneal implants. Vision impairment and corneal blindness have become fairly prominent in recent years. The latest estimates by the World Health Organization (WHO) reveal that almost 2.2 billion people globally have a distance or near vision impairment.
The widely expanding patient pool has encouraged industry participants and researchers to undertake R&D projects focusing on developing advanced tools and technologies. The integration of cutting-edge technologies in corneal implants lets eye surgeons be more precise in their treatments, reduces recovery times, decreases the risk of complications, and improves surgery outcomes. For instance, the advent of a femtosecond laser helped overcome suture-associated issues and attain a high grade of customization in corneal transplants.
The corneal implant market is categorized based on tissue, transplant, condition, end-user, and region.
With respect to tissue, the artificial cornea segment is predicted to showcase a remarkable growth rate from 2022 to 2030. The surging incidences of end-stage corneal diseases, such as inflammatory ocular surface disease and multiple graft failures, will boost the adoption of artificial corneal implants over the next eight years. Besides, the limited cornea donations with respect to the number of patients seeking transplantation treatment will augment the market size.
In terms of transplants, the others segment size was valued at over USD 35 billion in 2021 and may witness lucrative growth through 2030. The segment comprises corneal transplantation procedures, including Descemet stripping automated endothelial keratoplasty (DSAEK) and deep anterior lamellar keratoplasty (DALK). DALK procedures cause minimal steroid-related complications and ensure easy follow-ups and better long-term graft revival, increasing their adoption in the forthcoming years.
With regard to condition, the other segment amassed more than 7% market share in 2021 and is poised to record a decent valuation by 2030. The rising incidences of several eye defects caused due to traumatic injury, penetrating injury, keratitis, and bullous keratopathy will drive segment revenues over the next eight years. In addition, the increasing number of patients undergoing corneal transplantation surgeries will create favorable growth scenarios for the corneal implants industry.
Ambulatory Surgical Centers are likely to become a major end-user in the forthcoming years, owing to the increasing customer inclination toward ASCs as a preferred treatment location for eye surgeries. ASCs are equipped with advanced eye care surgeons and advanced tools and equipment, boosting their growth through 2030. These establishments offer same-day surgical care and better outpatient experience, providing them a competitive edge over clinics and hospitals.
The Latin America corneal implant market is projected to observe more than 6.5% growth rate from 2022 to 2030. The regional business is fueled by the massive growth in the geriatric population and the increasing number of people undergoing eye care treatments. In addition, improved access to medical facilities, the availability of all types of corneal inlays, and higher demand from ophthalmologists are a few promising aspects that may contribute towards regional market expansion.
Table of Contents
Chapter 1 Methodology & Scope
- 1.1 Market definitions
- 1.2 Base estimates & working
- 1.3 Forecast parameters
- 1.4 Data validation
- 1.5 Data sources
- 1.5.1 Secondary
- 1.5.1.1 Paid sources
- 1.5.1.2 Unpaid sources
- 1.5.2 Primary
Chapter 2 Executive Summary
- 2.1 Corneal Implants industry 360 degree synopsis, 2017 - 2030
- 2.1.1 Business trends
- 2.1.2 Tissue type trends
- 2.1.3 Transplant type trends
- 2.1.4 Condition trends
- 2.1.5 End-use trends
- 2.1.6 Regional trends
Chapter 3 Corneal Implants Industry Insights
- 3.1 Industry segmentation
- 3.2 Industry landscape, 2017 - 2030
- 3.3 Industry impact forces
- 3.3.1 Growth drivers
- 3.3.1.1 Increasing incidence of eye diseases worldwide
- 3.3.1.2 Rising elderly population in developed economies
- 3.3.1.3 Growing demand for minimally invasive surgical procedure across the globe
- 3.3.1.4 Increasing technological advancements in corneal implants
- 3.3.2 Industry pitfalls & challenges
- 3.3.2.1 Risks associated with corneal implants
- 3.3.2.2 Shortage of donor material worldwide
- 3.4 Growth potential analysis
- 3.4.1 By tissue type
- 3.4.2 By transplant type
- 3.4.3 By condition
- 3.4.4 By end-use
- 3.5 COVID- 19 impact analysis
- 3.6 Porter's analysis
- 3.7 Competitive landscape, 2021
- 3.8 PESTEL analysis
Chapter 4 Corneal Implants Market, By Tissue Type
- 4.1 Key segment trends
- 4.2 Human donor
- 4.2.1 Market size, by region, 2017 - 2030 (USD Million)
- 4.3 Artificial cornea
- 4.3.1 Market size, by region, 2017 - 2030 (USD Million)
Chapter 5 Corneal Implants Market, By Transplant Type
- 5.1 Key segment trends
- 5.2 Anterior lamellar keratoplasty (ALK)
- 5.2.1 Market size, by region, 2017 - 2030 (USD Million)
- 5.3 Endothelial lamellar keratoplasty (ELK)
- 5.3.1 Market size, by region, 2017 - 2030 (USD Million)
- 5.4 Penetrating keratoplasty (PK)
- 5.4.1 Market size, by region, 2017 - 2030 (USD Million)
- 5.5 Others
- 5.5.1 Market size, by region, 2017 - 2030 (USD Million)
Chapter 6 Corneal ImplantsMarket, By Condition
- 6.1 Key segment trends
- 6.2 Fungal keratitis
- 6.2.1 Market size, by region, 2017 - 2030 (USD Million)
- 6.3 Fuchs' dystrophy
- 6.3.1 Market size, by region, 2017 - 2030 (USD Million)
- 6.4 Keratoconous
- 6.4.1 Market size, by region, 2017 - 2030 (USD Million)
- 6.5 Others
- 6.5.1 Market size, by region, 2017 - 2030 (USD Million)
Chapter 7 Corneal ImplantsMarket, By End-use
- 7.1 Hospitals
- 7.1.1 Market size, by region, 2017 - 2030 (USD Million)
- 7.2 Eye clinics
- 7.2.1 Market size, by region, 2017 - 2030 (USD Million)
- 7.3 Ambulatory surgical cenetrs
- 7.3.1 Market size, by region, 2017 - 2030 (USD Million)
Chapter 8 Corneal ImplantsMarket, By Region
- 8.1 Key regional trends
- 8.2 North America
- 8.2.1 Market size, by country, 2017 - 2030 (USD Million)
- 8.2.2 Market size, by tissue type, 2017 - 2030 (USD Million)
- 8.2.3 Market size, by transplant type, 2017 - 2030 (USD Million)
- 8.2.4 Market size, by condition, 2017 - 2030 (USD Million)
- 8.2.5 Market size, by end-use, 2017 - 2030 (USD Million)
- 8.2.6 U.S.
- 8.2.6.1 Market size, by tissue type, 2017 - 2030 (USD Million)
- 8.2.6.2 Market size, by transplant type, 2017 - 2030 (USD Million)
- 8.2.6.3 Market size, by condition, 2017 - 2030 (USD Million)
- 8.2.6.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 8.2.7 Canada
- 8.2.7.1 Market size, by tissue type, 2017 - 2030 (USD Million)
- 8.2.7.2 Market size, by transplant type, 2017 - 2030 (USD Million)
- 8.2.7.3 Market size, by condition, 2017 - 2030 (USD Million)
- 8.2.7.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 8.3 Europe
- 8.3.1 Market size, by country, 2017 - 2030 (USD Million)
- 8.3.2 Market size, by tissue type, 2017 - 2030 (USD Million)
- 8.3.3 Market size, by transplant type, 2017 - 2030 (USD Million)
- 8.3.4 Market size, by condition, 2017 - 2030 (USD Million)
- 8.3.5 Market size, by end-use, 2017 - 2030 (USD Million)
- 8.3.6 Germany
- 8.3.6.1 Market size, by tissue type, 2017 - 2030 (USD Million)
- 8.3.6.2 Market size, by transplant type, 2017 - 2030 (USD Million)
- 8.3.6.3 Market size, by condition, 2017 - 2030 (USD Million)
- 8.3.6.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 8.3.7 UK
- 8.3.7.1 Market size, by tissue type, 2017 - 2030 (USD Million)
- 8.3.7.2 Market size, by transplant type, 2017 - 2030 (USD Million)
- 8.3.7.3 Market size, by condition, 2017 - 2030 (USD Million)
- 8.3.7.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 8.3.8 France
- 8.3.8.1 Market size, by tissue type, 2017 - 2030 (USD Million)
- 8.3.8.2 Market size, by transplant type, 2017 - 2030 (USD Million)
- 8.3.8.3 Market size, by condition, 2017 - 2030 (USD Million)
- 8.3.8.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 8.3.9 Italy
- 8.3.9.1 Market size, by tissue type, 2017 - 2030 (USD Million)
- 8.3.9.2 Market size, by transplant type, 2017 - 2030 (USD Million)
- 8.3.9.3 Market size, by condition, 2017 - 2030 (USD Million)
- 8.3.9.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 8.3.10 Spain
- 8.3.10.1 Market size, by tissue type, 2017 - 2030 (USD Million)
- 8.3.10.2 Market size, by transplant type, 2017 - 2030 (USD Million)
- 8.3.10.3 Market size, by condition, 2017 - 2030 (USD Million)
- 8.3.10.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 8.4 Asia Pacific
- 8.4.1 Market size, by country, 2017 - 2030 (USD Million)
- 8.4.2 Market size, by tissue type, 2017 - 2030 (USD Million)
- 8.4.3 Market size, by transplant type, 2017 - 2030 (USD Million)
- 8.4.4 Market size, by condition, 2017 - 2030 (USD Million)
- 8.4.5 Market size, by end-use, 2017 - 2030 (USD Million)
- 8.4.6 Japan
- 8.4.6.1 Market size, by tissue type, 2017 - 2030 (USD Million)
- 8.4.6.2 Market size, by transplant type, 2017 - 2030 (USD Million)
- 8.4.6.3 Market size, by condition, 2017 - 2030 (USD Million)
- 8.4.6.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 8.4.7 China
- 8.4.7.1 Market size, by tissue type, 2017 - 2030 (USD Million)
- 8.4.7.2 Market size, by transplant type, 2017 - 2030 (USD Million)
- 8.4.7.3 Market size, by condition, 2017 - 2030 (USD Million)
- 8.4.7.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 8.4.8 India
- 8.4.8.1 Market size, by tissue type, 2017 - 2030 (USD Million)
- 8.4.8.2 Market size, by transplant type, 2017 - 2030 (USD Million)
- 8.4.8.3 Market size, by condition, 2017 - 2030 (USD Million)
- 8.4.8.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 8.4.9 South Korea
- 8.4.9.1 Market size, by tissue type, 2017 - 2030 (USD Million)
- 8.4.9.2 Market size, by transplant type, 2017 - 2030 (USD Million)
- 8.4.9.3 Market size, by condition, 2017 - 2030 (USD Million)
- 8.4.9.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 8.4.10 Australia
- 8.4.10.1 Market size, by tissue type, 2017 - 2030 (USD Million)
- 8.4.10.2 Market size, by transplant type, 2017 - 2030 (USD Million)
- 8.4.10.3 Market size, by condition, 2017 - 2030 (USD Million)
- 8.4.10.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 8.5 Latin America
- 8.5.1 Market size, by country, 2017 - 2030 (USD Million)
- 8.5.2 Market size, by tissue type, 2017 - 2030 (USD Million)
- 8.5.3 Market size, by transplant type, 2017 - 2030 (USD Million)
- 8.5.4 Market size, by condition, 2017 - 2030 (USD Million)
- 8.5.5 Market size, by end-use, 2017 - 2030 (USD Million)
- 8.5.6 Brazil
- 8.5.6.1 Market size, by tissue type, 2017 - 2030 (USD Million)
- 8.5.6.2 Market size, by transplant type, 2017 - 2030 (USD Million)
- 8.5.6.3 Market size, by condition, 2017 - 2030 (USD Million)
- 8.5.6.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 8.5.7 Mexico
- 8.5.7.1 Market size, by tissue type, 2017 - 2030 (USD Million)
- 8.5.7.2 Market size, by transplant type, 2017 - 2030 (USD Million)
- 8.5.7.3 Market size, by condition, 2017 - 2030 (USD Million)
- 8.5.7.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 8.5.8 Argentina
- 8.5.8.1 Market size, by tissue type, 2017 - 2030 (USD Million)
- 8.5.8.2 Market size, by transplant type, 2017 - 2030 (USD Million)
- 8.5.8.3 Market size, by condition, 2017 - 2030 (USD Million)
- 8.5.8.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 8.6 Middle East & Africa
- 8.6.1 Market size, by country, 2017 - 2030 (USD Million)
- 8.6.2 Market size, by tissue type, 2017 - 2030 (USD Million)
- 8.6.3 Market size, by transplant type, 2017 - 2030 (USD Million)
- 8.6.4 Market size, by condition, 2017 - 2030 (USD Million)
- 8.6.5 Market size, by end-use, 2017 - 2030 (USD Million)
- 8.6.6 South Africa
- 8.6.6.1 Market size, by tissue type, 2017 - 2030 (USD Million)
- 8.6.6.2 Market size, by transplant type, 2017 - 2030 (USD Million)
- 8.6.6.3 Market size, by condition, 2017 - 2030 (USD Million)
- 8.6.6.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 8.6.7 Saudi Arabia
- 8.6.7.1 Market size, by tissue type, 2017 - 2030 (USD Million)
- 8.6.7.2 Market size, by transplant type, 2017 - 2030 (USD Million)
- 8.6.7.3 Market size, by condition, 2017 - 2030 (USD Million)
- 8.6.7.4 Market size, by end-use, 2017 - 2030 (USD Million)
- 8.6.8 UAE
- 8.6.8.1 Market size, by tissue type, 2017 - 2030 (USD Million)
- 8.6.8.2 Market size, by transplant type, 2017 - 2030 (USD Million)
- 8.6.8.3 Market size, by condition, 2017 - 2030 (USD Million)
- 8.6.8.4 Market size, by end-use, 2017 - 2030 (USD Million)
Chapter 9 Company Profiles
- 9.1 Strategy dashboard, 2021
- 9.2 Alabama Eye Bank Inc.
- 9.2.1 Business overview
- 9.2.2 Financial data
- 9.2.3 Product landscape
- 9.2.4 Strategic outlook
- 9.2.5 Swot analysis
- 9.3 Alcon Inc.
- 9.3.1 Business overview
- 9.3.2 Financial data
- 9.3.3 Product landscape
- 9.3.4 Strategic outlook
- 9.3.5 Swot analysis
- 9.4 DIPOTEX
- 9.4.1 Business overview
- 9.4.2 Financial data
- 9.4.3 Product landscape
- 9.4.4 Strategic outlook
- 9.4.5 Swot analysis
- 9.5 Florida Lions Eye Bank
- 9.5.1 Business overview
- 9.5.2 Financial data
- 9.5.3 Product landscape
- 9.5.4 Strategic outlook
- 9.5.5 Swot analysis
- 9.6 Presbia PLC
- 9.6.1 Business overview
- 9.6.2 Financial data
- 9.6.3 Product landscape
- 9.6.4 Strategic outlook
- 9.6.5 Swot analysis
- 9.7 CorneaGen
- 9.7.1 Business overview
- 9.7.2 Financial data
- 9.7.3 Product landscape
- 9.7.4 Strategic outlook
- 9.7.5 Swot analysis
- 9.8 CorNeat Vision Ltd.
- 9.8.1 Business overview
- 9.8.2 Financial data
- 9.8.3 Product landscape
- 9.8.4 Strategic outlook
- 9.8.5 Swot analysis
- 9.9 Aurolab
- 9.9.1 Business overview
- 9.9.2 Financial data
- 9.9.3 Product landscape
- 9.9.4 Strategic outlook
- 9.9.5 Swot analysis
- 9.10 KeraMed Inc.
- 9.10.1 Business overview
- 9.10.2 Financial data
- 9.10.3 Product landscape
- 9.10.4 Strategic outlook
- 9.10.5 Swot analysis
- 9.11 AJL Ophthalmic SA
- 9.11.1 Business overview
- 9.11.2 Financial data
- 9.11.3 Product landscape
- 9.11.4 Strategic outlook
- 9.11.5 Swot analysis
- 9.12 Massachusetts Eye and Ear
- 9.12.1 Business overview
- 9.12.2 Financial data
- 9.12.3 Product landscape
- 9.12.4 Strategic outlook
- 9.12.5 Swot analysis
- 9.13 MEDIPHACOS
- 9.13.1 Business overview
- 9.13.2 Financial data
- 9.13.3 Product landscape
- 9.13.4 Strategic outlook
- 9.13.5 Swot analysis
- 9.14 MicroKpro
- 9.14.1 Business overview
- 9.14.2 Financial data
- 9.14.3 Product landscape
- 9.14.4 Strategic outlook
- 9.14.5 Swot analysis